Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to journals
Academic JournalOpen Access

PeerJ

2 Papers Indexed in Blossom

Published Papers

Open Accessindividual

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression

This open-label study (n=94) finds that baseline plasma BDNF concentrations (a protein related to nerve growth) correlate with ketamine (6 infusions, 35mg/70kg) antidepressant effects (MADRS).

Published
March 29, 2021
Journal
PeerJ
Authors
Zheng, W., Zhou, Y. L., Wang, C. Y., Lan, X. F., Zhang, B., Zhou, S. M., Yan, S., Ning, Y. P.
Open Accessindividual

Harmine stimulates proliferation of human neural progenitors

Harmine markedly increases proliferation of human neural progenitor cells (hNPCs) derived from pluripotent stem cells, enlarging the proliferating pool by 71.5% after four days in vitro. The proliferation was mimicked by the DYRK1A inhibitor INDY but not by the MAO inhibitor pargyline, implicating DYRK1A inhibition as a likely mechanism and potentially explaining harmine’s antidepressant effects.

Published
December 6, 2016
Journal
PeerJ
Authors
Dakic, V., De Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., Rehen, S. K.

Quick Facts

Papers Indexed
2
h-Index
124
Open Access
Yes
Publisher
Taylor & Francis
Country
United States
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.